It’s Getting Harder to Save for a Down Payment, But First-Time Buyers Have New Opportunities in the Great Reshuffling

Flexible work arrangements and low mortgage rates can help first-time buyers overcome down payment difficulties

– First-time buyers today need a year longer to save for a 20% down payment than they did five years ago.

– Renters will need to save an additional $369 per month in the coming year just to keep up with the forecasted growth in home values.

– Most first-time buyers put down less than 20%, but today’s low mortgage rates mean monthly payments can remain affordable with a smaller down payment.

PR Newswire

SEATTLE, July 8, 2021 /PRNewswire/ — Starter home prices are growing almost seven times faster than renter incomes, making what was likely already the biggest challenge for first-time home buyers ― saving for a down payment ― even more difficult. But there is good news for today’s first-time buyers: With mortgage rates near record lows, monthly payments can remain affordable even with a smaller down payment, and flexible work options are providing new opportunities for many to buy a home in a less-expensive city.

If an average renter household saves 10% of its income ― an aggressive target given the average renter savings rate is 2.4% ― it would take about six years and five months to save enough for a 20% down payment on today’s typical starter home, worth about $148,500. That’s a full year longer than it would have taken to save for a down payment on a starter home five years ago, a new Zillow® analysis indicates. And as prices rise at a record pace, it may take even longer for today’s renters to save up for tomorrow’s homes. 

“Without the equity from a previous home sale, first-time home buyers face more challenges in coming up with a down payment,” says Zillow economic data analyst Nicole Bachaud. “In a housing market where prices are rising at record rates, especially when compared to renter incomes, the ever-increasing sum of a 20% down payment can feel out of reach. The good news is that buyers who want to take advantage of today’s low mortgage rates can do so without putting a full 20% down ― most conventional mortgages allow as little as 3% to 5%. That lower upfront payment comes with higher monthly payments, but the opportunity to build equity can outweigh those extra costs for many.”

Prices for even the most affordable homes are rising quickly. As of May, homes priced in the bottom third of a given metro area, often thought of as starter homes for first-time buyers, are growing faster than the typical mid-market home in 42 of the 50 largest U.S. metro areas. Those who are just starting to save may need to factor in this rapid pace of home value growth. Zillow forecasts 14.9% appreciation over the next year, which would mean renters need to save an additional $369 per month just to keep up. 

Renters in California face the biggest barriers to saving for down payments. San Francisco renters earn nearly twice as much money as the typical U.S. renter, yet home prices are so high that it would take 17 years and five months ― 11 years longer than the national average ― to save enough to put 20% down on a local starter home. It would take even longer in Los Angeles and San Diego. Among the top 50 metro areas, renters in Birmingham, Memphis and Detroit could save for a down payment the fastest. 

While this may seem daunting, it’s possible to secure a mortgage while putting less than 20% down. In fact, a majority (64%) of first-time buyers do so, and one-quarter put down 5% or less.i Renters can save up a 10% down payment on a typical starter home after three years and three months, and accruing a 5% down payment would take only a year and seven months. 

A smaller down payment, of course, comes with tradeoffs on the monthly mortgage payment, such as the private mortgage insurance lenders often require borrowers to carry. At today’s rates, the mortgage payment on a typical starter home with 20% down would be $501, while a 5% down payment would be $730 ― still only 18.9% of a typical renter’s monthly income, well below the 30% rule of thumb for housing affordability. Buyers may decide the benefits of homeownership and the chance to build equity sooner outweigh the additional housing cost burden each month.

The new freedom for many to work remotely and live anywhere as part of the Great Reshuffling may also help many renters move into homeownership, as renters in high-cost areas can more easily save for a home in a less expensive locale. A typical San Francisco renter, if able to do their job remotely, could save enough for a 20% down payment on a starter home in Austin in about six years and eight months, and a similar home in Phoenix in five years and seven months. A similar renter in Boston could save enough for a 20% down payment on a starter home in Miami in half the time it would take for a local starter home ― six and a half years, instead of 13 years. On the other hand, a typical renter in Austin hoping to make a move to San Francisco would need to save for 28 years and three months.

Because of differences in incomes and the lingering impacts of historical inequities, it is more difficult for Black and Latinx renters to come up with a down payment on their first home. It would take six years and one month for a white renter earning the median income, and four and a half years for an Asian American renter earning the median income to save for a 20% down payment on a starter home, compared with nine years and seven months for a Black renter, and seven years and eight months for a Latinx renter. 

Black and Latinx home buyers are more likely than white home buyers to say they saved at least part of their down payment themselvesii ― which could be a possible consequence of the racial wealth gap, as Black and Latinx buyers are often less able to rely on family to help out financially. Along with structural barriers such as less access to credit and higher rates of mortgage-application denials, this is a contributing factor to the racial homeownership gap. 


Years to Save for a Down Payment on
a Starter Home (10% savings rate)


Monthly Mortgage
Payment**


Metro Area*


Typical Home
Value for a Starter
Home


20% Down


10% Down


5% Down


20%
Down


10%
Down


5%
Down

United States

$148,527

6.4

3.2

1.6

$709

$900

$938

New York, NY

$346,426

11.7

5.9

2.9

$1,686

$2,131

$2,220

Los Angeles, CA

$562,810

17.6

8.8

4.4

$2,309

$3,031

$3,177

Chicago, IL

$173,458

7.5

3.7

1.9

$930

$1,153

$1,198

Dallas–Fort Worth, TX

$206,828

7.4

3.7

1.8

$1,136

$1,401

$1,455

Philadelphia, PA

$177,999

7.7

3.9

1.9

$899

$1,128

$1,174

Houston, TX

$173,750

7.2

3.6

1.8

$973

$1,197

$1,242

Washington, D.C.

$333,276

9.3

4.7

2.3

$1,445

$1,873

$1,959

Miami–Fort Lauderdale, FL

$199,601

8.3

4.1

2.1

$980

$1,237

$1,288

Atlanta, GA

$195,579

7.4

3.7

1.8

$896

$1,148

$1,198

Boston, MA

$399,275

13.0

6.5

3.3

$1,834

$2,347

$2,450

San Francisco, CA

$846,415

17.4

8.7

4.4

$3,470

$4,557

$4,776

Detroit, MI

$103,890

5.0

2.5

1.3

$533

$667

$694

Riverside, CA

$337,914

13.2

6.6

3.3

$1,497

$1,931

$2,018

Phoenix, AZ

$270,560

10.6

5.3

2.7

$1,133

$1,481

$1,551

Seattle, WA

$440,927

12.2

6.1

3.0

$1,913

$2,479

$2,593

Minneapolis–St. Paul, MN

$249,454

10.3

5.2

2.6

$1,197

$1,518

$1,582

San Diego, CA

$555,114

17.9

9.0

4.5

$2,305

$3,018

$3,161

St. Louis, MO

$109,997

5.3

2.7

1.3

$552

$694

$722

Tampa, FL

$183,060

8.0

4.0

2.0

$899

$1,134

$1,182

Baltimore, MD

$204,501

7.8

3.9

2.0

$922

$1,184

$1,237

Denver, CO

$391,057

12.5

6.3

3.1

$1,647

$2,149

$2,250

Pittsburgh, PA

$104,869

5.4

2.7

1.3

$538

$673

$700

Portland, OR

$389,626

12.7

6.4

3.2

$1,730

$2,230

$2,331

Charlotte, NC

$188,506

7.8

3.9

2.0

$841

$1,083

$1,132

Sacramento, CA

$392,326

14.2

7.1

3.6

$1,695

$2,199

$2,301

San Antonio, TX

$160,885

7.2

3.6

1.8

$862

$1,069

$1,110

Orlando, FL

$206,898

8.3

4.2

2.1

$985

$1,250

$1,304

Cincinnati, OH

$144,529

7.0

3.5

1.8

$723

$908

$946

Cleveland, OH

$109,078

5.7

2.8

1.4

$588

$728

$756

Kansas City, MO

$142,629

6.0

3.0

1.5

$713

$896

$933

Las Vegas, NV

$245,552

11.0

5.5

2.8

$1,041

$1,356

$1,419

Columbus, OH

$153,948

6.4

3.2

1.6

$806

$1,004

$1,044

Indianapolis, IN

$133,009

6.1

3.0

1.5

$620

$791

$825

San Jose, CA

$940,490

16.6

8.3

4.1

$3,802

$5,009

$5,253

Austin, TX

$323,686

10.8

5.4

2.7

$1,676

$2,091

$2,175

Virginia Beach, VA

$190,730

8.0

4.0

2.0

$854

$1,099

$1,148

Nashville, TN

$227,995

8.5

4.3

2.1

$1,001

$1,293

$1,352

Providence, RI

$290,309

14.1

7.0

3.5

$1,423

$1,796

$1,871

Milwaukee, WI

$140,699

6.4

3.2

1.6

$733

$914

$950

Jacksonville, FL

$173,644

6.9

3.5

1.7

$822

$1,045

$1,090

Memphis, TN

$87,918

4.7

2.4

1.2

$439

$552

$575

Oklahoma City, OK

$112,498

5.8

2.9

1.5

$572

$716

$745

Louisville, KY

$134,060

6.6

3.3

1.7

$623

$795

$830

Hartford, CT

$189,579

9.1

4.5

2.3

$1,028

$1,271

$1,320

Richmond, VA

$190,164

8.2

4.1

2.0

$826

$1,071

$1,120

New Orleans, LA

$155,339

9.0

4.5

2.3

$743

$942

$982

Raleigh, NC

$229,948

8.3

4.2

2.1

$1,019

$1,314

$1,374

Birmingham, AL

$91,806

4.7

2.3

1.2

$396

$514

$537

Salt Lake City, UT

$372,094

13.7

6.9

3.4

$1,550

$2,027

$2,124

*Table ordered by market size

**Total monthly payments assume a 3% mortgage rate, including property taxes, insurance and PMI for down payments of less than 20%

About
 Zillow Group
Zillow Group, Inc. (NASDAQ: Z and ZG) is reimagining real estate to make it easier to unlock life’s next chapter. 

As the most-visited real estate website in the United States, Zillow® and its affiliates offer customers an on-demand experience for selling, buying, renting or financing with transparency and nearly seamless end-to-end service. Zillow Offers® buys and sells homes directly in dozens of markets across the country, allowing sellers control over their timeline. Zillow Home Loans™, our affiliate lender, provides our customers with an easy option to get pre-approved and secure financing for their next home purchase. Zillow recently launched Zillow Homes, Inc., a licensed brokerage entity, to streamline Zillow Offers transactions.  

Zillow Group’s brands, affiliates and subsidiaries include Zillow®; Zillow Offers®; Zillow Premier Agent®; Zillow Home Loans™; Zillow Closing Services™; Zillow Homes, Inc.; Trulia®; Out East®; StreetEasy® and HotPads®. Zillow Home Loans, LLC is an Equal Housing Lender, NMLS #10287 (www.nmlsconsumeraccess.org).  

i  Zillow Consumer Housing Trends Report, 2020
ii  Zillow Consumer Housing Trends Report, 2020

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/its-getting-harder-to-save-for-a-down-payment-but-first-time-buyers-have-new-opportunities-in-the-great-reshuffling-301327689.html

SOURCE Zillow

Landsea Homes Opens For Sale In North Central Phoenix

Two communities with 53 single-family homes and four different floorplans

Communities surrounded by local flavor, popular shops, and delicious eateries

High-Performance Homes designed for healthier and more comfortable living

PR Newswire

PHOENIX, July 8, 2021 /PRNewswire/ — Landsea Homes Corporation (Nasdaq: LSEA) (“Landsea Homes” or the “Company”), a publicly traded residential homebuilder, announced today that homes will open for sale in North Central Phoenix, Arizona beginning Saturday, July 17th.

Madison Square consists of 40 single-family homes. An extension of the Madison Square community, 14th at Town & Country is a rare enclave of 13 additional single-family homes located just blocks away.

“Our two exciting communities of Madison Square and 14th at Town & Country embody the intersection of desert cool and urban sophistication,” said Todd Condon, Vice President of Sales and Marketing, Landsea Homes Arizona Division. “With access to great schools, trendy shops, and high-end dining, as well as outdoor recreation, the homes are in a highly sought-after area of Phoenix that we know will be very popular with buyers.”

In advance of the first sales release, Landsea Homes will also be hosting an informative webinar on Saturday, July 10th for those who pre-register. The webinar will provide attendees exclusive information for the sales release on July 17th. To register for the webinar, visit: https://us02web.zoom.us/webinar/register/WN_u3eDazrcSjC_R6tKTYoWWA

These 53 single-family homes feature four diverse floorplans and flexible styles, with prices beginning in the $690k’s.

  • Biltmore – Single-family homes from approximately 2,068 square feet, including three to four bedrooms, two and a half bathrooms, a versatile loft space, and a two-car garage.
  • Central – Single-family homes from approximately 2,245 square feet including four to five bedrooms, three to four bathrooms, and a versatile loft space that can be transitioned into a 5th bedroom, home office, or space to relax.
  • Midtown – Single-family homes from approximately 2,400 square feet including five bedrooms, three to four bathrooms, a two-car garage and an array of luxury features from a large walk-in kitchen pantry to walk-in bedroom closets.
  • Uptown – Single-family homes from approximately 2,707 square feet including five bedrooms plus a versatile teen room, four and a half bathrooms, a downstairs study, and covered patio allowing for entertainment space and work from home flexibility.

The communities exciting locations offer extensive recreation opportunities with close proximity to The Phoenix Mountain Preserve, Echo Canyon Trailhead, as well as the Biltmore Fashion Park – allowing residents to explore the scenic and sunshine-filled Sonoran Desert, upscale shopping and fine dining.

Families are also close to highly performing elementary schools and retirees will find the plan’s mix of designs flexible in style and size

All homes at Madison Square and 14th at Town & Country are High-Performance Homes, which are designed to respect the planet while saving money and keeping residents safe. The home automation REME HALO® air purifier will keep residents healthier and more comfortable than in your typical family home.

“Instead of using passive air filtration, we chose the active REME HALO® air purification system as a standard feature in our homes to provide homebuyers the best indoor air quality available,” said Todd Condon. 

Madison Square and 14th at Town & Country are located in North Central Phoenix, Arizona. For more information, please visit https://landseahomes.com/arizona/madison-square/.

About Landsea Homes Corporation

Landsea Homes Corporation (Nasdaq: LSEA) is a publicly traded residential homebuilder based in Newport Beach, CA that designs and builds best-in-class homes and sustainable master-planned communities in some of the nation’s most desirable markets. The company has developed homes and communities in New York, Boston, New Jersey, Arizona, Florida, Texas and throughout California in Silicon Valley, Los Angeles and Orange County.

An award-winning homebuilder that builds suburban, single-family detached and attached homes, mid-and high-rise properties, and master-planned communities, Landsea Homes is known for creating inspired places that reflect modern living and provides homebuyers the opportunity to “Live in Your Element.” Our homes allow people to live where they want to live, how they want to live – in a home created especially for them. 

Driven by a pioneering commitment to sustainability, Landsea Homes’ High Performance Homes are responsibly designed to take advantage of the latest innovations with home automation technology supported by Apple®. Homes include features that make life easier and provide energy savings that allow for more comfortable living at a lower cost through sustainability features that contribute to healthier living for both homeowners and the planet. 

Led by a veteran team of industry professionals who boast years of worldwide experience and deep local expertise, Landsea Homes is committed to positively enhancing the lives of our homebuyers, employees and stakeholders by creating an unparalleled lifestyle experience that is unmatched.

For more information on Landsea Homes, visit: www.landseahomes.com. 

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/landsea-homes-opens-for-sale-in-north-central-phoenix-301327583.html

SOURCE Landsea Homes

Enveric Biosciences Announces Approval from Israel’s Ministry of Health to Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma

Enveric Enters into Clinical Stage Development of Lead Asset, EV101, in Israel with MOH Approval

PR Newswire

NAPLES, Fla., July 8, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel cannabinoid medicines to improve quality of life for cancer patients, announced today that the Company has received approval from the Israeli Ministry of Health to begin the Phase 1/2 portion of its study of its lead asset, EV101, designed to investigate the safety and efficacy of synthetic cannabidiol (CBD) when administered alone or in combination with clomiphene, concurrently with temozolomide, to treat patients suffering from recurrent or progressive glioblastoma (GBM). The study will be conducted at the Davidoff Institute of Oncology, Rabin Medical Center, in Israel under Principal Investigator Dr. Tali Siegal.

“Glioblastoma is a highly aggressive form of cancer with a very poor overall survival rate, particularly for those with recurrent GBM, which is the target group for this study,” said Robert Wilkins, M.D., Chief Medical Officer, Enveric Biosciences. “Our goal with this study is to enhance the existing treatment’s efficacy through adding CBD to create a new standard of care, potentially improving and extending glioblastoma patients’ quality of life.”

The Phase 1 portion of the study is intended to first determine the CBD-temozolomide combination’s maximum tolerated dose (MTD). Clomiphene will then be added to the regimen for up to 24 patients to rule out toxicity. Once all three agents’ MTDs are determined, they will then be applied to the Phase 2 portion to determine initial efficacy, where an additional 40 patients are expected to be recruited and randomized into two open-label treatment arms.

The study design is as follows:

  • Arm 1 (combination): Patients will be treated with the MTD determined in the dose-finding phase for pure synthetic CBD oil + temozolomide. 
  • Arm 2 (triple combination): Patients will be treated with the MTD determined in the dose-finding phase for pure synthetic CBD oil + temozolomide + clomiphene.
  • All patients will continue treatment for up to 24 months from Day 1 of the therapy unless unacceptable toxicities, patient consent withdrawal or death occur.

“We believe that the Israeli Ministry of Health’s approval for this Phase 1/2 study is a major milestone not only for Enveric but also for glioblastoma patients globally who are seeking to prolong their survival and improve their quality of life,” added David Johnson, Chairman and CEO of Enveric Biosciences. “Our goal is to further demonstrate CBD’s efficacy when combined with current anti-cancer drugs to optimize the existing standard-of-care for cancer patients in need. We are targeting the fourth quarter of 2021 for the enrollment of our first patient, following the conclusion of the final study agreements with the site.”

This product is not approved for marketing anywhere in the world.

About Enveric Biosciences
Enveric Biosciences is a patient-first biotechnology company developing rigorously tested, novel cannabinoid medicines to improve quality of life for cancer patients. Initial indications include radiodermatitis, a common and often severe side effect of radiation therapy, and chemotherapy-induced neuropathy. For more information, please visit https://www.enveric.com/.

Forward-Looking Statements
This press release contains forward-looking statements and forward-looking information within the meaning of applicable securities laws. These statements relate to future events or future performance. All statements other than statements of historical fact may be forward-looking statements or information. Generally, forward-looking statements and information may be identified by the use of forward-looking terminology such as “plans”, ” expects” or “does not expect”, “proposed”, “is expected”, “budgets”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases, or by the use of words or phrases which state that certain actions, events or results may, could, would, or might occur or be achieved. Forward-looking statements consist of statements that are not purely historical, including any statements regarding beliefs, plans, expectations or intentions regarding the future.  Such forward-looking statements are based on the beliefs of management as well as assumptions made by and information currently available to management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors, including, but not limited to, the impact of the novel coronavirus (COVID-19) on Enveric’s ongoing and planned clinical trials; the geographic, social and economic impact of COVID-19 on Enveric’s ability to conduct its business and raise capital in the future when needed; delays in planned clinical trials; the ability to establish that potential products are efficacious or safe in preclinical or clinical trials; the ability to establish or maintain collaborations on the development of therapeutic candidates; the ability to obtain appropriate or necessary governmental approvals to market potential products; the ability to obtain future funding for developmental products and working capital and to obtain such funding on commercially reasonable terms; Enveric’s ability to manufacture product candidates on a commercial scale or in collaborations with third parties; changes in the size and nature of competitors; the ability to retain key executives and scientists; and the ability to secure and enforce legal rights related to Enveric’s products, including patent protection. A discussion of these and other factors, including risks and uncertainties with respect to Enveric, is set forth in Enveric’s filings with the Securities and Exchange Commission (SEC), including the Company’s Annual Report on Form 10-K and its Quarterly Reports on Form 10-Q. Enveric disclaims any intention or obligation to revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Investor Contacts

Valter Pinto / Allison Soss
KCSA Strategic Communications
212.896.1254 / 212.896.1267
[email protected] / [email protected] 

Media Contacts

Caitlin Kasunich / Raquel Cona
KCSA Strategic Communications
212.896.1241 / 212.896.1204
[email protected] / [email protected] 

 

Cision View original content:https://www.prnewswire.com/news-releases/enveric-biosciences-announces-approval-from-israels-ministry-of-health-to-begin-its-phase-12-trial-of-triple-combination-cbd-treatment-for-glioblastoma-301327782.html

SOURCE Enveric Biosciences

Atos and IBM to Collaborate to Build a Secured Infrastructure for the Dutch Ministry of Defense

New Infrastructure to become the Digital Backbone for the Dutch Ministry as Armed Forces Transforms into an Information-Driven Organization

PR Newswire

PARIS and ARMONK, N.Y., July 8, 2021 /PRNewswire/ — Atos and IBM (NYSE: IBM) today announced their plans to collaborate to build a new, highly-advanced digital infrastructure for the Dutch Ministry of Defense. The Dutch Ministry of Defense plans to use advanced technologies, infrastructure services, and expertise from Atos and IBM Global Technology Services to construct new data centers, safeguard its IT system, and build a proprietary broadband mobile network to help ensure classified government information remains protected.

“Our work on Groundbreaking IT (GrIT) marks our continued commitment to building secure infrastructures that help global customers accelerate their digital transformations,” said Peter `t Jong, Head of Atos in The Netherlands. “By collaborating with IBM, a world-class partner with deep experience in helping government organizations across the globe modernize with advanced technology, we will help enable the Ministry to build an agile organization based on a reliable, secured, future-ready and flexible digital infrastructure.”

Atos and IBM announced the expansion of their strategic global alliance in January 2021 with the goal of transforming digital acceleration, increased productivity, and reduced operating costs for their customers. Today’s announcement reinforces the companies’ collaboration and mutual commitment to helping customers use open hybrid cloud and AI to accelerate digital transformation.

“Collaborating on GrIT with Atos, one of our sustainability-focused global ecosystem partners, reinforces our mission to build secure infrastructures using open hybrid cloud to help customers make their organizations future ready,” said Evaristus Mainsah, GM, IBM Hybrid Cloud and Edge Ecosystem. “Together, we’re helping customers, like the Dutch Ministry of Defense, accelerate their digital transformations by streamlining operations and increasing productivity in a most secured environment.”

About Atos  

Atos is a global leader in digital transformation with 105,000 employees and annual revenue of over € 11 billion. European number one in cybersecurity, cloud and high performance computing, the Group provides tailored end-to-end solutions for all industries in 71 countries. A pioneer in decarbonization services and products, Atos is committed to a secure and decarbonized digital for its clients. Atos operates under the brands Atos and Atos|Syntel. Atos is a SE (Societas Europaea), listed on the CAC40 Paris stock index.

The purpose of Atos is to help design the future of the information space. Its expertise and services support the development of knowledge, education and research in a multicultural approach and contribute to the development of scientific and technological excellence. Across the world, the Group enables its customers and employees, and members of societies at large to live, work and develop sustainably, in a safe and secure information space. www.atos.net

About IBM 

IBM is a leading global hybrid cloud and AI, and business services provider.  We help clients in more than 175 countries capitalize on insights from their data, streamline business processes, reduce costs and gain the competitive edge in their industries.  Nearly 3,000 government and corporate entities in critical infrastructure areas such as financial services, telecommunications and healthcare rely on IBM’s hybrid cloud platform and Red Hat OpenShift to affect their digital transformations quickly, efficiently and securely.  IBM’s breakthrough innovations in AI, quantum computing, industry-specific cloud solutions and business services deliver open and flexible options to our clients.  All of this is backed by IBM’s legendary commitment to trust, transparency, responsibility, inclusivity and service.

For more information, visit www.ibm.com

Press contact: Marion Delmas | [email protected] | +33 6 37 63 91 99

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/atos-and-ibm-to-collaborate-to-build-a-secured-infrastructure-for-the-dutch-ministry-of-defense-301327845.html

SOURCE IBM

Jack Henry’s Chief Risk Officer Named Board Chair of The Institute of Internal Auditors

Audit and risk management veteran Charlie Wright contributes to international professional organization

PR Newswire

MONETT, Mo., July 8, 2021 /PRNewswire/ — Jack Henry & Associates, Inc.® (NASDAQ: JKHY) is a leading provider of technology solutions and payment processing services primarily for the financial services industry. Today, the company announced that Charlie Wright, chief risk officer for Jack Henry, was named board chair of The Institute of Internal Auditors (IIA) Global Board of Directors.

The IIA is the internal audit profession’s global voice, recognized authority, acknowledged leader, chief advocate, and principal educator. Its mission is to provide dynamic leadership for the global profession of internal auditing. Wright, a Certified Internal Auditor (CIA), has been an active part of the organization for many years and has served on the Global Board since 2014, most recently as senior vice chair. He also was vice chair of Finance and of Professional Guidance, chair of North American Advocacy committee and of the Global Committee Task Force, and member of the Three Lines Model task force. He’s also a frequent presenter at IIA conferences.

As board chair, Wright will lead the 17-member Global Board, chair the Supervisory Committee, and preside over the General Assembly. His introductory keynote will discuss how internal auditors can prepare for the future as advances in technology create opportunities and challenges for the profession.

IIA president and CEO Anthony J. Pugliese, CPA, CGMA, CITP, said, “Charlie Wright has made a huge impact on The IIA through his longtime involvement and leadership. We’re proud to have him now serve as Global Chair and look forward to his support as we continue to grow, educate, and elevate the internal audit profession around the world.”

Wright is an experienced chief audit executive with more than 35 years of corporate experience in the airline, energy, and financial services industry. In addition to being a Certified Internal Auditor, Wright is a Certified Public Accountant (CPA), and Certified Information Systems Auditor (CISA). At Jack Henry, he oversees the internal audit function as well as information security, enterprise risk management, occupational risk management, regulatory and compliance, third-party risks, asset protection, and enterprise continuity.

David Foss, board chair, president and chief executive officer for Jack Henry, added, “The addition of Charlie Wright as the board chair of IIA is a strategic and smart move. Charlie is an experienced professional who continues to seek new opportunities to learn, collaborate and grow both professionally and personally. The same talents, insights, and knowledge that help direct Jack Henry’s strategic course will be a strong benefit to IIA. On behalf of Jack Henry, we congratulate him on taking on such a big role at IIA and look forward to exploring opportunities where we can collaborate and provide support across organizations.”

About Jack Henry & Associates, Inc.
Jack Henry (NASDAQ: JKHY) is a leading SaaS provider primarily for the financial services industry. We are a S&P 500 company that serves approximately 8,500 clients nationwide through three divisions: Jack Henry Banking® provides innovative solutions to community and regional banks; Symitar® provides industry-leading solutions to credit unions of all sizes; and ProfitStars® offers highly specialized solutions to financial institutions of every asset size, as well as diverse corporate entities outside of the financial services industry. With a heritage that has been dedicated to openness, partnership, and user centricity for more than 40 years, we are well-positioned as a driving market force in cloud-based digital solutions and payment processing services. We empower our clients and consumers with the human-centered, tech-forward, and insights-driven solutions that will get them where they want to go. Are you future ready? Additional information is available at www.jackhenry.com.

Cision View original content:https://www.prnewswire.com/news-releases/jack-henrys-chief-risk-officer-named-board-chair-of-the-institute-of-internal-auditors-301327697.html

SOURCE Jack Henry & Associates, Inc.

Cisco Completes Acquisition of Socio Labs

News Summary:

– Cisco completes acquisition of Socio Labs, Inc. to expand Webex offerings beyond meetings, webinars and webcasts to include conferences and power the future of hybrid events.

– Socio Labs’ hybrid event management platform is expected to be seamlessly integrated into the Webex Suite soon.

PR Newswire

SAN JOSE, Calif., July 8, 2021 /PRNewswire/ — Cisco (NASDAQ: CSCO) today announced the completion of the acquisition of privately-held, U.S.-based Socio Labs, Inc. Socio is a modern event technology platform that manages the full lifecycle of multi-session, multi-track virtual, in-person and hybrid conferences – from registration to post-event analytics.

By adding Socio Labs to its Webex portfolio, Cisco will provide event organizers a single platform with everything they need to successfully host nearly any type of event imaginable. Benefits include the ability to create: 

  • Equally inclusive experiences for both in-person and virtual attendees during events of any type, size and format
  • Highly customizable branded registration and ticketing experiences, dynamic ads, customized profiles and sponsor booths including gamification and lead generation components
  • Actionable data about event attendees, sponsors, exhibitors and more, offering deeper insight into attendee interests
  • Always-on, continuous engagement with attendees across multiple events, leveraging data about their virtual and in-person event behaviors and preferences to build personalized journeys

“Being able to offer novel, refreshing and inclusive experiences for all attendees – whether in person or virtual – is paramount in today’s new era of hybrid events,” said Jeetu Patel, executive vice president and general manager, Cisco Security and Collaboration. “The acquisition of Socio Labs is another example of how Cisco is rapidly addressing the evolving needs of our Webex customers and continuing to execute on our vision of providing the most seamless, inclusive, engaging and intelligent platform for meetings and events.”

“Cisco shares in our commitment to creating technology that drives authentic connections and personalized experiences, which is one of the many reasons why joining forces with Cisco is great for our team and our customers,” said Yarkin Sakucoglu, Socio Labs co-founder and CEO. “Together, we will be able to accelerate this mission and continue building the best event technology platform for the hybrid future of events.”

The Socio Labs team joins Cisco’s Collaboration Group.

About Cisco
Cisco (NASDAQ: CSCO) is the worldwide leader in technology that powers the Internet. Cisco inspires new possibilities by reimagining your applications, securing your data, transforming your infrastructure, and empowering your teams for a global and inclusive future. Discover more on The Network and follow us on Twitter at @Cisco.

About Webex by Cisco
Webex is a leading provider of cloud-based collaboration solutions which includes video meetings, calling, messaging, events, customer experience solutions like contact center and purpose-built collaboration devices. At Webex, we start with people and their experiences first. This focus on delivering inclusive collaboration experiences fuels our innovation, which leverages AI and Machine Learning, to remove the barriers of geography, language, personality and familiarity with technology. Our solutions are underpinned with security and privacy by design. We work with the world’s leading business and productivity apps – delivered through a single application and interface. Learn more at webex.com.

Forward-Looking Statements
This press release may be deemed to contain forward-looking statements, which are subject to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements regarding the acquisition enabling the expansion of Webex offerings, the expected benefits to Cisco and its customers from completing the acquisition, and plans regarding Socio Labs, Inc. personnel. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual future events or results due a variety of factors, including, among other things,  the potential impact on the business of Socio Labs, Inc. due to the uncertainty about the acquisition, the retention of employees of Socio Labs, Inc. and the ability of Cisco to successfully integrate Socio Labs, Inc. and to achieve expected benefits, business and economic conditions and growth trends in the networking industry, customer markets and various geographic regions, global economic conditions and uncertainties in the geopolitical environment and other risk factors set forth in Cisco’s most recent reports on Form 10-K and Form 10-Q. Any forward-looking statements in this release are based on limited information currently available to Cisco, which is subject to change, and Cisco will not necessarily update the information.

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/cisco-completes-acquisition-of-socio-labs-301327416.html

SOURCE Cisco Systems, Inc.

Nuance Named a 2021 “Best Company to Sell For”

Receives top accolades by Selling Power for second consecutive year

PR Newswire

BURLINGTON, Mass., July 8, 2021 /PRNewswire/ — Nuance Communications, Inc. (NASDAQ: NUAN) announced today that it has been recognized as a “Best Company to Sell For” in Selling Power‘s 2021 Best Companies to Sell For list.  Selling Power magazine evaluates companies worldwide based on their Sales culture, compensation and benefits, onboarding and sales enablement strategies, and sales training and coaching.  This year, Selling Power also focused on how companies pivoted to help their Sales teams be successful in a digital, remote selling environment.

“We have a world-class, purpose-driven sales force who are committed to delivering the best conversational AI solutions that drive powerful, real-world outcomes for our customers,” said Robert Dahdah, Nuance’s Chief Revenue Officer. “They are well-respected experts in their industries and, as a company, we continue to invest in them with programs and resources that support their growth and help them be their absolute best— for themselves and those we collectively serve.”

Nuance is proud to be recognized by Selling Power for the second consecutive year.  This distinction is the latest in a growing number of Employer of Choice accolades that the company has recently received, including Best Places to Work for Moms, Best Places to Work for Dads, Best Places for Parents Working Remotely, “Montréal’s Top Employers” for 2021 award, one of the Human Rights Campaign Foundation’s 2021’s “Best Places to Work for LGBTQ Equality,” the #1 Best Place to Work by Built In Boston, a Top Employer by the Boston Globe, a one of Boston Business Journal‘s Best Places to Work in 2021, a certified “Great Place to Work” by the Great Places to Work Institute in the U.S., and a certified “Great Place to Work in India” by the Great Places to Work Institute.

“Our employees are the reason Nuance is such a great place to work and why we can deliver market-leading technology to our customers that is trusted by the largest companies around the world,” said Beth Conway, Nuance’s Executive Vice President and Chief People & Places Officer. “We are committed to fostering a culture where our employees can thrive, and providing them with an environment that empowers, inspires, and supports their varying needs.”

With a deep commitment to supporting its global employees and the communities in which they live and work, Nuance offers competitive benefits and leave policies, as well as professional development and continuing education opportunities, employee resource groups, flexible work schedules, paid time off to volunteer, and health and wellness programs. 

To learn more about Nuance and the career opportunities currently available, visit jobs.nuance.com.

About Nuance Communications, Inc.

Nuance Communications (NASDAQ: NUAN) is a technology pioneer with market leadership in conversational AI and ambient intelligence. A full-service partner trusted by 77 percent of U.S. hospitals and 85 percent of the Fortune 100 companies worldwide, Nuance creates intuitive solutions that amplify people’s ability to help others.

Trademark reference: Nuance and the Nuance logo are registered trademarks or trademarks of Nuance Communications, Inc. or its affiliates in the United States and/or other countries. All other trademarks referenced herein are the property of their respective owners.


Media Contacts

Nuance Communications

Nancy Scott

+1 781.565.4130
[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/nuance-named-a-2021-best-company-to-sell-for-301327487.html

SOURCE Nuance Communications, Inc.

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

PR Newswire

BRIDGEWATER, N.J., July 8, 2021 /PRNewswire/ — Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards to 12 new employees. In accordance with NASDAQ Listing Rule 5635(c)(4), the awards were approved by Insmed’s Compensation Committee and made as a material inducement to each employee’s entry into employment with the Company.

In connection with the commencement of their employment, the employees received options on July 1, 2021 to purchase an aggregate 72,350 shares of Insmed common stock at an exercise price of $29.47 per share, the closing trading price on the Nasdaq Global Select Market on the date of grant.

The options have a ten-year term and a four-year vesting schedule, with 25% of the shares subject to the option vesting on the first anniversary of the relevant grant date and 12.5% of the shares subject to the option vesting every six months thereafter through the fourth anniversary of the relevant grant date, subject to the relevant employee’s continued service with Insmed on the applicable vesting date.

About
 
Insmed

Insmed Incorporated is a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases. Insmed’s first commercial product is a first-in-disease therapy approved in the United States, Europe, and Japan to treat a chronic, debilitating lung disease. The Company is also progressing a robust pipeline of investigational therapies targeting areas of serious unmet need, including neutrophil-mediated inflammatory diseases and rare pulmonary disorders. Insmed is headquartered in Bridgewater, New Jersey, with a growing footprint across Europe and in Japan. For more information, visit www.insmed.com.

Contact:

Investors:

Eleanor Barisser
Associate Director, Investor Relations
Insmed
(718) 594-5332
[email protected] 

Media:

Mandy Fahey

Senior Director, Corporate Communications
Insmed
(732) 718-3621
[email protected]

 

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/insmed-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-301327328.html

SOURCE Insmed Incorporated

Notice of Release of Barrick’s Second Quarter 2021 Results

TORONTO, July 08, 2021 (GLOBE NEWSWIRE) — Barrick will release its Q2 2021 results on Monday, August 9, 2021. President and CEO Mark Bristow will host a virtual presentation on the results that day at 11:00 EDT, with an interactive webinar linked to a conference call. Participants will be able to ask questions.

The company will release its preliminary production, sales and cost information for Q2 2021 on July 15, 2021.

  • Release of Q2 preliminary production, sales and cost information

    July 15, 07:00 EDT / 11:00 UTC

Q2 RESULTS ANNOUNCEMENT        

  • Q2 Results release

    August 9, 6:00 EDT / 10:00 UTC

  • Q2 Results webinar

    August 9, 11:00 EDT / 15:00 UTC
    Go to the webinar

  • Conference call linked to webinar

    August 9, 11:00 EDT / 15:00 UTC
    US/Canada (toll-free), 1 800 319 4610
    UK (toll-free), 0808 101 2791
    International (toll), +1 416 915 3239

The webinar will remain on the website for later viewing and the conference call will be available for replay by telephone at 1 855 669 9658 (US and Canada toll-free) and +1 604 674 8052 (international toll), access code 7159.

The Q2 2021 presentation materials will be available on Barrick’s website at www.barrick.com.

Enquiries:

Claudia Pitre
Manager, Investor Relations and Corporate Access                
+1 416 307 5105
Email: [email protected]

Kathy du Plessis
Investor and Media Relations
+44 20 7557 7738
Email: [email protected]

Website:
www.barrick.com



Vor Biopharma Announces Collaboration with Janssen to Develop Engineered Hematopoietic Stem Cell Transplants Combined With a Bi-Specific Antibody Therapy for Acute Myeloid Leukemia (AML)

CAMBRIDGE, Mass., July 08, 2021 (GLOBE NEWSWIRE) — Vor Biopharma (Nasdaq: VOR or the Company), a cell therapy company pioneering engineered hematopoietic stem cell (eHSC) therapies combined with targeted therapies for the treatment of cancer, today announced the formation of a collaboration with Janssen Biotech, Inc. (“Janssen”), one of the Janssen Pharmaceutical Companies of Johnson & Johnson. The agreement was facilitated by Johnson & Johnson Innovation.

Under the terms of the collaboration, Vor Biopharma will investigate the combination of these two technologies into a treatment solution, pairing Vor’s “invisible” eHSC transplant platform with one of Janssen’s bi-specific antibodies in development for acute myeloid leukemia (AML).  

“We are thrilled to enter into this collaboration with Janssen as we continue to explore our platform’s potential to pair with a broad spectrum of targeted therapy modalities for the treatment of patients with blood cancer,” said Tirtha Chakraborty, PhD, Vor’s Chief Scientific Officer. “We believe this unique combination will leverage each technology’s strengths, while protecting patients against off-target effects of these powerful immunotherapies.”

The collaboration agreement provides that each company retains all rights and ownership to their respective programs and platforms.

About Vor Biopharma

Vor Biopharma is a cell therapy company that aims to transform the lives of cancer patients by pioneering engineered hematopoietic stem cell (eHSC) therapies to create next-generation, treatment-resistant transplants that unlock the potential of targeted therapies. By removing biologically redundant proteins from eHSCs, we design these cells and their progeny to be treatment-resistant to complementary targeted therapies, thereby enabling these therapies to selectively destroy cancer cells while sparing healthy cells.

Forward Looking Statements

This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “project,” “should,” “target,” “will,” “would,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements in this press release include the Company’s statements regarding its platform’s potential to treat patients suffering from acute myeloid leukemia. The Company may not actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements, and you should not place undue reliance on these forward-looking statements. Actual results or events could differ materially from the plans, intentions and expectations disclosed in these forward-looking statements as a result of various factors, including: uncertainties inherent in the initiation and completion of preclinical studies and clinical trials and clinical development of the Company’s product candidates; availability and timing of results from preclinical studies and clinical trials; whether interim results from a clinical trial will be predictive of the final results of the trial or the results of future trials; expectations for regulatory approvals to conduct trials or to market products and availability of funding sufficient for the Company’s foreseeable and unforeseeable operating expenses and capital expenditure requirements.  These and other risks are described in greater detail under the caption “Risk Factors” included in the Company’s most recent annual or quarterly report and in other reports the Company has filed or may file with the Securities and Exchange Commission. Any forward-looking statements contained in this press release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements, whether because of new information, future events or otherwise, except as may be required by law.

Contacts:

Investors:
Chris Brinzey
Westwicke, an ICR Company
+1 339-970-2843
[email protected]

Media:
Rebecca Spalding
Ten Bridge Communications
+1 646-509-3831
[email protected]